Education
About Us
Working with TipRanks
Follow Us
Halberd Corporation (HALB)
OTHER OTC:HALB
HALB Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume347.04K
Average Volume (3M)1.38M
Market Cap
$1.13M
Enterprise ValueN/A
Total Cash (Recent Filing)$6.67K
Total Debt (Recent Filing)$150.00K
Price to Earnings (P/E)―
Beta1.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding515,874,800
10 Day Avg. Volume2,869,156
30 Day Avg. Volume1,377,709
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)-2.21
Price to Sales (P/S)0.00
P/FCF Ratio-25.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
HALB FAQ
What was Halberd Corporation’s price range in the past 12 months?
Halberd Corporation lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Halberd Corporation’s market cap?
Halberd Corporation’s market cap is $1.13M.
When is Halberd Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Halberd Corporation’s earnings last quarter?
Currently, no data Available
Is Halberd Corporation overvalued?
According to Wall Street analysts Halberd Corporation’s price is currently Overvalued.
Does Halberd Corporation pay dividends?
Halberd Corporation does not currently pay dividends.
What is Halberd Corporation’s EPS estimate?
Halberd Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Halberd Corporation have?
Halberd Corporation has 515,874,800 shares outstanding.
What happened to Halberd Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Halberd Corporation?
Currently, no hedge funds are holding shares in HALB
---
Company Description
Halberd Corporation
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
---
Scorpius Holdings
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―
---